Private Equity Partnerships in Orthopedic Groups: Current State and Key ConsiderationsJournal of Orthopaedic Experience & Innovation November 14, 2020
Gary W. Herschman, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Newark office, and Hector M. Torres, Managing Director at FocalPoint LLC, co-authored an article in the Journal of Orthopaedic Experience & Innovation, titled “Private Equity Partnerships in Orthopedic Groups: Current State and Key Considerations.”
Following is an excerpt (see below to download the full version in PDF format):
The orthopedic physician group sector remains an attractive area of investment for private equity because the demand for orthopedic care is high, yet the supply of orthopedic surgeons in the U.S. is relatively low. This supply and demand imbalance provides for long-term sustainable growth of orthopedic services within a highly fragmented clinical specialty. With an approximate $1.8 trillion dollars of private equity capital ready to be deployed within the healthcare services industry, private equity remains an increasingly more available option to orthopedic practices. While partnerships among and between orthopedic groups and private equity firms can result in significant benefits, in today’s environment, private equity may also serve as an advantageous pathway for independent orthopedic groups to bolster their financial strength and better position themselves to weather the post-COVID-19 storm.